LLY.F - Eli Lilly and Company

Frankfurt - Frankfurt Prix différé. Devise en EUR

Eli Lilly and Company

Lilly Corporate Center
Indianapolis, IN 46285
United States
317 276 2000

Secteur d’activitéDrug Manufacturers—General
Employés à temps plein39 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. David A. RicksChairman, CEO & Pres4,42MS.O.1968
Ms. Anat AshkenaziExec. VP & CFO2,13MS.O.1973
Dr. Daniel M. Skovronsky M.D., Ph.D.Exec. VP, Chief Scientific & Medical Officer and Pres of Lilly Research Laboratories2,72MS.O.1974
Ms. Anat Hakim J.D.Exec. VP, Gen. Counsel & Sec.1,98MS.O.1969
Mr. Patrik JonssonEVP, Chief Customer Officer, Pres of Lilly USA & Lilly Immunology1,67MS.O.1967
Mr. Donald A. ZakrowskiChief Accounting Officer & VP of Fin.S.O.S.O.S.O.
Mr. Diogo RauEVP & Chief Information and Digital OfficerS.O.S.O.S.O.
Mr. Alonzo WeemsEVP of Enterprise Risk Management and Chief Ethics & Compliance OfficerS.O.S.O.1971
Ms. Leigh Ann PuseyExec. VP of Corp. Affairs & CommunicationsS.O.S.O.1963
Mr. Eric DozierExec. VP of HR & DiversityS.O.S.O.1967
Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en EUR.


Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Eli Lilly and Company en date du 1 juin 2023 est 5. Les scores principaux sont Audit : 3; Société : 5; Droits des actionnaires : 9; Compensation : 1.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.